Pharma-Bio Serv (PBSV) Enterprise Value (2010 - 2026)

Pharma-Bio Serv (PBSV) has reported Enterprise Value for 17 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Enterprise Value rose 2013.76% year-over-year to $3.0 million; the trailing twelve-month figure through Apr 2026 stood at $3.0 million (up 2013.76% YoY), and the FY2025 full-year result was $1.5 million, up 165.61% from the prior year.
• Enterprise Value advanced to $3.0 million in Q2 2026 per PBSV's latest filing, from $3.0 million in the prior quarter.
• Across five years, Enterprise Value topped out at $10.0 million in Q3 2023 and bottomed at $140911.5 in Q2 2025.
• Historically, Enterprise Value has averaged $4.5 million across 5 years, with a median of $3.6 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Enterprise Value slumped 96.0% in 2025, then surged 2013.76% in 2026.
• Over 5 years, Enterprise Value stood at $5.3 million in 2022, then slipped by 13.8% to $4.5 million in 2023, then sank by 87.44% to $570262.6 in 2024, then surged by 165.61% to $1.5 million in 2025, then surged by 96.65% to $3.0 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered $3.0 million, $3.0 million, and $1.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.